Jurgen Bajorath

Person

Mountlake Terrace, WA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Expression vectors encoding bispecific fusion proteins and methods...
- Patent number 7,915,395
- Issue date Mar 29, 2011
- Bristol-Myers Squibb Company
- Jeffrey A. Ledbetter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treatment using CTLA4 mutant molecules
- Patent number 7,439,230
- Issue date Oct 21, 2008
- Bristol-Myers Squibb Company
- Robert J. Peach
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
ICOS mutants
- Patent number 7,235,631
- Issue date Jun 26, 2007
- Mayo Foundation for Medical Education and Research
- Lieping Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Soluble CTLA4 mutant molecules and uses thereof
- Patent number 7,105,166
- Issue date Sep 12, 2006
- Bristol-Myers Squibb Company
- Peter S. Linsley
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Soluble CTLA4 mutant molecules
- Patent number 7,094,874
- Issue date Aug 22, 2006
- Bristol-Myers Squibb Co.
- Robert J. Peach
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Expression vectors encoding bispecific fusion proteins and methods...
- Patent number 6,482,919
- Issue date Nov 19, 2002
- Bristol-Myers Squibb Company
- Jeffrey A. Ledbetter
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods of using antibodies against human CD40
- Patent number 6,413,514
- Issue date Jul 2, 2002
- Bristol-Myers Squibb Company
- Alejandro A. Aruffo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Monoclonal antibodies to human CD6
- Patent number 6,372,215
- Issue date Apr 16, 2002
- Bristol-Myers Squibb Company
- Gary C. Starling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies against human CD40
- Patent number 6,312,693
- Issue date Nov 6, 2001
- Alejandro A. Aruffo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Expression vectors encoding bispecific fusion proteins and methods...
- Patent number 6,132,992
- Issue date Oct 17, 2000
- Bristol-Myers Squibb Co.
- Jeffrey A. Ledbetter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Composition and method for enhancing fibrinolysis
- Patent number 6,114,506
- Issue date Sep 5, 2000
- General Hospital Corporation
- Guy L. Reed
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CTLA4/CD28Ig hybrid fusion proteins and uses thereof
- Patent number 6,090,914
- Issue date Jul 18, 2000
- Bristol-Myers Squibb Company
- Peter S. Linsley
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies against human CD40
- Patent number 6,051,228
- Issue date Apr 18, 2000
- Bristol-Myers Squibb Co.
- Alejandro A. Aruffo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Monoclonal antibodies specific for different epitopes of human GP39...
- Patent number 5,876,950
- Issue date Mar 2, 1999
- Bristol-Myers Squibb Company
- Anthony W. Siadak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Expression vectors encoding bispecific fusion proteins and methods...
- Patent number 5,637,481
- Issue date Jun 10, 1997
- Bristol-Myers Squibb Company
- Jeffrey A. Ledbetter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
3,5,3'-triiodothyronine receptor ligands
- Patent number 5,585,404
- Issue date Dec 17, 1996
- Ulf Norinder
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Receptor ligands
- Patent number 5,567,728
- Issue date Oct 22, 1996
- Karobio Aktiebolag
- Ulf Norinder
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
COMPOUNDS, COMPOSITIONS AND METHODS FOR INHIBITING OR TREATING HIV-1
- Publication number 20060264475
- Publication date Nov 23, 2006
- CYTOKINE PHARMASCIENCES, INC.
- Omar K. HAFFAR
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Soluble CTLA4 mutant molecules and uses thereof
- Publication number 20050214313
- Publication date Sep 29, 2005
- Robert J. Peach
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds, compositions and methods for inhibiting or treating HIV-1
- Publication number 20050203150
- Publication date Sep 15, 2005
- Omar K. Haffar
- C07 - ORGANIC CHEMISTRY
Information Patent Application
System for performing median partitioning as a method for diversity...
- Publication number 20040197934
- Publication date Oct 7, 2004
- Jurgen Bajorath
- G06 - COMPUTING CALCULATING COUNTING
Information Patent Application
Soluble CTLA4 mutant molecules and uses thereof
- Publication number 20040014171
- Publication date Jan 22, 2004
- Bristol -Myers Squibb Company
- Robert James Peach
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Soluble CTLA4 mutant molecules and uses thereof
- Publication number 20030219863
- Publication date Nov 27, 2003
- Bristol -Myers Squibb Company
- Robert J. Peach
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Expression vectors encoding bispecific fusion proteins and methods...
- Publication number 20030219876
- Publication date Nov 27, 2003
- Bristol -Myers Squibb Company
- Jeffrey A. Ledbetter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ICOS mutants
- Publication number 20030158102
- Publication date Aug 21, 2003
- Lieping Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods for treatment of cancer or neoplastic disease and for inhib...
- Publication number 20030119894
- Publication date Jun 26, 2003
- Gemin X Biotechnologies Inc.
- Madiraju S.R. Murthy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SOLUBLE CTLA4 MUTANT MOLECULES AND USES THEREOF
- Publication number 20030035816
- Publication date Feb 20, 2003
- ROBERT JAMES PEACH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Soluble CTLA4 mutant molecules and uses thereof
- Publication number 20020182211
- Publication date Dec 5, 2002
- Robert J. Peach
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Expression vectors encoding bispecific fusion proteins and methods...
- Publication number 20020012989
- Publication date Jan 31, 2002
- Bristol -Myers Squibb Company
- Jeffrey A. Ledbetter
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Jurgen Bajorath

Person

Patents Grantslast 30 patents

Expression vectors encoding bispecific fusion proteins and methods...

Methods of treatment using CTLA4 mutant molecules

ICOS mutants

Soluble CTLA4 mutant molecules and uses thereof

Soluble CTLA4 mutant molecules

Expression vectors encoding bispecific fusion proteins and methods...

Methods of using antibodies against human CD40

Monoclonal antibodies to human CD6

Antibodies against human CD40

Expression vectors encoding bispecific fusion proteins and methods...

Composition and method for enhancing fibrinolysis

CTLA4/CD28Ig hybrid fusion proteins and uses thereof

Antibodies against human CD40

Monoclonal antibodies specific for different epitopes of human GP39...

Expression vectors encoding bispecific fusion proteins and methods...

3,5,3'-triiodothyronine receptor ligands

Receptor ligands

Patents Applicationslast 30 patents

COMPOUNDS, COMPOSITIONS AND METHODS FOR INHIBITING OR TREATING HIV-1

Soluble CTLA4 mutant molecules and uses thereof

Compounds, compositions and methods for inhibiting or treating HIV-1

System for performing median partitioning as a method for diversity...

Soluble CTLA4 mutant molecules and uses thereof

Soluble CTLA4 mutant molecules and uses thereof

Expression vectors encoding bispecific fusion proteins and methods...

ICOS mutants

Methods for treatment of cancer or neoplastic disease and for inhib...

SOLUBLE CTLA4 MUTANT MOLECULES AND USES THEREOF

Soluble CTLA4 mutant molecules and uses thereof

Expression vectors encoding bispecific fusion proteins and methods...